NVision
About
NVision was established as a spin-off from the University of Ulm's Institute of Quantum Optics and Institute of Theoretical Physics, leveraging nitrogen-vacancy centers in diamond for quantum sensing applications in medical imaging. Founded by Prof. Fedor Jelezko, Prof. Martin Plenio, Prof. Alex Retzker, and Ilai Schwartz (CTO), with Dr. Sella Brosh serving as CEO. The company raised $30 million Series A in June 2023 to deploy quantum-powered hyperpolarizers for MRI imaging, enabling earlier cancer treatment assessment. NVision's technology fundamentally changes medical MRI by dramatically improving sensitivity through dynamic nuclear polarization using NV centers in diamond. The company bridges quantum physics and clinical medicine.
Categories
Qubit Technology
Key People
Sella Brosh (CEO), Ilai Schwartz (CTO, Co-founder), Fedor Jelezko (Co-founder), Martin Plenio (Co-founder), Alex Retzker (Co-founder)
Request Information
Interested in NVision? Get pricing, demos, or technical details.
Request Information
Get in touch with NVision about your project.
Claim This Profile
Are you from NVision? Verify your association to update your listing and receive notifications.
Claim Your Profile
Verify you represent NVision to update your listing.
Quick Facts
Links
Location
Loading map...
Stay Updated
Get the latest quantum computing news delivered to your inbox.